Physiology and pathophysiology of musculoskeletal aging: current research trends and future priorities. by Mobasheri, A & Mendes, AF
EDITORIAL
published: 09 April 2013
doi: 10.3389/fphys.2013.00073
Physiology and pathophysiology of musculoskeletal aging:
current research trends and future priorities
Ali Mobasheri1*† and Alexandrina F. Mendes2
1 Faculty of Medicine and Health Sciences, Medical Research Council-Arthritis Research UK Centre for Musculoskeletal Ageing Research, Arthritis Research UK
Pain Centre, Arthritis Research UK Centre for Sport, Exercise, and Osteoarthritis, The University of Nottingham, Nottingham, UK
2 Faculty of Pharmacy and Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal
*Correspondence: ali.mobasheri@nottingham.ac.uk
Edited by:
Paul M. Janssen, Ohio State University, USA
Reviewed by:
Paul M. Janssen, Ohio State University, USA
“Physiology and Pathophysiology of Musculoskeletal Aging” is a
Frontiers Research Topic aimed at increasing our understanding
of healthy musculoskeletal aging. By gaining a better understand-
ing of healthy musculoskeletal aging we can provide better care
and new therapies for common musculoskeletal problems.
Sarcopenia is a term utilized to define the loss of muscle mass
and strength and the consequent functional impairment that
occurs with aging (Baumgartner et al., 1999; Waters et al., 2000;
Morley et al., 2001). It can begin as early as the third decade of
life. However, in most cases it affects individuals in the fourth
decade and beyond. The gradual loss of muscle tissue (atrophy)
reduces total body mass. Decreased physical activity with aging
appears to be the key factor involved in producing sarcopenia
(Morley et al., 2001). The age-related alterations inmuscle involve
age-related muscle fiber transitions and metabolic shifts in aging
muscle. These alterations also affect posture and gait and become
particularly evident in the seventh, eighth, and ninth decades of
life. Mitchell and colleagues highlight these issues by reviewing
the current knowledge of the decline in human muscle mass and
strength with advancing age and the associated risk to health and
survival (Mitchell et al., 2012). They also review the underlying
changes in muscle characteristics and the etiology of sarcope-
nia. The authors draw on evidence from cross-sectional studies
that have compared young and old muscle to show that in peo-
ple aged 75 years, muscle mass is lost at a rate of 0.64–0.70% per
year in women and 0.80–0.98% per year in men with more rapid
concomitant losses in muscle strength; loss of muscle strength is
thought to be 2–5 times greater than loss of mass. The loss of mus-
cle strength is a more consistent risk factor for the development
of disability and death than loss of muscle mass (Mitchell et al.,
2012).
In their review article David Karasik and Miri Cohen-Zinder
fromBar-IlanUniversity argue the need for identification of genes
with pleiotropic functions in musculoskeletal aging (Karasik and
Cohen-Zinder, 2012). The authors point out thatmusculoskeletal
aging is detrimental to multiple bodily functions. This is a chal-
lenging area given the fact that the process of musculoskeletal
aging becomes apparent in the fourth decade of an individ-
ual’s life. Exploring pleiotropic relationships is difficult both
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methodologically and conceptually. However, in order to identify
the biological mechanisms underlying these changes we need a
“holistic” genetic approach to investigate the cross-talk between
muscle and closely related tissues (i.e., tendon, bone, and carti-
lage). This strategy may allow us to find the links between skeletal
muscle and other parts of the “musculoskeleton” (Karasik and
Cohen-Zinder, 2012).
Kay Ohlendieck takes a molecular approach to musculoskele-
tal aging by reviewing the applications of proteomic profiling to
aging muscle and the “fast-to-slow” muscle transitions that are
thought to occur during aging (Ohlendieck, 2011a). The author
has recently published a review article that discusses current
proteomic approaches for studying skeletal muscle and associ-
ated technical challenges and emerging techniques (Ohlendieck,
2011b). His review article in this Research Topic discusses pro-
teomic profiling approaches that have helped to establish an
age-related shift to slower protein isoforms of myosin heavy
chain, myosin light chain, actin and tropomyosin, as well as
subunits of troponin (Ohlendieck, 2011a). These studies have
confirmed previous assertions concerning the disproportionate
age-related atrophy of type IIa muscle fibers and an age-related
decrease in the synthesis rate of myosin heavy chain (Morley et al.,
2001). Ohlendieck’s mini-review also discusses the “glycolytic-to-
oxidative” shift that occurs in slower-twitching senescent muscles
and the newly identified proteins that are altered in aging muscle
using proteomic profiling (Ohlendieck, 2011a). Proteomic profil-
ing has also revealed an increase in mitochondrial enzymes and
a concomitant decrease in glycolytic enzymes during the fast-to-
slow transformation process in aging skeletal muscle. This timely
mini-review which has previously been accompanied by a ded-
icated Editorial (Mobasheri, 2011b) also discusses alterations in
metabolic and contractile elements that can be used to define a
“sarcopenia-specific” biomarker signature.
Aging is also a major contributor to the development and
progression of osteoarthritis (OA). OA is a long and slow con-
tinuum of joint changes and symptoms that has no clear-cut
onset (Englund, 2010). Therefore, the use of “omics” technolo-
gies offers great promise for understanding factors that contribute
to disease initiation and progression and how they are affected
by aging.
Gharbi and co-workers (Gharbi et al., 2011) review the appli-
cations of proteomic techniques in OA research. One of the
main objectives of applying proteomics to the study of cartilage
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aging and OA is to discover disease-specific biomarkers, which
may reveal new therapeutic targets and facilitate targeted drug
development. Gharbi et al., summarize proteomic techniques
and their applications to OA research and discuss technical lim-
itations and practical problems associated with sample prepa-
ration and strategies to overcome them. Proteomic studies of
cartilage and other joint tissues will be particularly relevant to
diagnostic and therapeutic research in OA (Mobasheri, 2011a).
Fernández-Moreno and colleagues from Blanco’s group
assess the link between a number of biomarkers and
the mitochondrion-related phenotype in patients with
OA (Fernandez-Moreno et al., 2012). They measured the
serum levels of the OA-related biomarkers including matrix
metalloproteinase-1 (MMP-1), matrix metalloproteinase-3
(MMP-3), matrix metalloproteinase-13 (MMP-13), myeloperoxi-
dase (MPO), hyaluronic acid (HA), human cartilage glycoprotein
39 (YKL-40), cartilage oligomeric matrix protein (COMP),
cathepsin K, and several peptides derived from type II collagen
including Coll2-1, Coll2-1NO2, C2C, and CPII. The biomarkers
were analyzed in 48 OA patients and 52 healthy controls carry-
ing the mitochondrial haplogroups H and J. MMP-13 was the
only biomarker that significantly increased in OA patients com-
pared to healthy controls in both mitochondrial haplogroups H
and J. The collagen type II biomarkers, Coll2-1, Coll2-1NO2, the
Coll2-1NO2/Coll2-1 ratio, C2C, CPII, and the C2C:CPII ratio
were significantly increased in OA patients carrying haplogroup
H compared to OA carriers of the haplogroup J. Therefore, mito-
chondrial DNA haplogroups are potentially useful biomarkers
of OA and may be used in conjunction with traditional protein
biomarkers (Fernandez-Moreno et al., 2012).
Adrian Hunnisett and Christina Cunliffe put forward a posi-
tioning paper on the role of chiropractic treatment as a primary
care intervention for better musculoskeletal health in the aging
population in the United Kingdom (Hunnisett and Cunliffe,
2012). The elderly are encouraged to take more exercise to ensure,
and maintain, musculoskeletal health. The authors propose chi-
ropractic treatment as an Intervention in musculoskeletal aging
and advocate patient-focused care for the management of muscu-
loskeletal disorders. Chiropractic intervention and maintenance
programs can promote health and ensure continued muscu-
loskeletal functioning of the elderly population and encourage the
mechanistic and evidence-based integration of chiropractic into
the National Health Service of the United Kingdom (Hunnisett
and Cunliffe, 2012).
Musculoskeletal aging is a complex process. It involves tissue
atrophy and loss of function in muscle, bone, tendon, liga-
ment, intervertebral disk, and articular cartilage. Musculoskeletal
aging is also accompanied by reduced neuromuscular integrity.
The progressive loss of musculoskeletal mass and function high-
lights the importance of physical activity and exercise in elderly
people. Increased adiposity (sarcopenic obesity) is another mech-
anism that contributes to age-related musculoskeletal deteriora-
tion. Increasing exercise capacity and physical fitness are likely
to results in regeneration and remodeling within musculoskeletal
tissue compartments. However, the molecular mechanisms that
underscore these changes are poorly understood. Understanding
age-related musculoskeletal deterioration requires co-ordinated
basic, clinical, and translational studies that can generate novel
and clinically testable approaches to healthier musculoskeletal
aging. The elegant and original articles in this Research Topic
highlight some of the major issues facing researchers in the area
of musculoskeletal health and aging. We hope that this Research
Topic will serve as a platform for encouraging further research
into musculoskeletal aging.
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